Atlas Trials

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Clinical trial NCT02451891 · TERMINATED

Trial details

NCT number
NCT02451891
Sponsor
University of Oxford
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Ebola Virus Disease
Start date
2015-05-06
Primary completion
2017-08-22
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.